Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury

PHASE3CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

February 29, 2004

Study Completion Date

May 31, 2004

Conditions
Spinal Cord InjuryMuscle Spasticity
Interventions
DRUG

Fampridine-SR

25mg bid (twice daily)

OTHER

Placebo

Placebo

Trial Locations (45)

10605

The Burke Rehabilitation Hospital, White Plains

15213

University of Pittsburgh, Pittsburgh

15238

HEALTHSOUTH Harmarville Rehabilitation Hospital, Pittsburgh

18103

Good Shepherd Rehabilitation, Allentown

18501

Northeastern Rehabilitation Associates, Scranton

19355

Bryn Mawr Rehabilitation Hospital, Malvern

19806

Neurology Associates, P.A., Wilmington

20010

National Rehabilitation Hospital, Washington D.C.

23249

Richmond VA Medical Center (Hunter Holmes McGuire), Richmond

23667

Hampton VA Hospital, Hampton

25304

CAMC Health Education & Research Institute, Charleston

27157

Wake Forest University, Winston-Salem

27599

UNC Chapel Hill, Chapel Hill

27858

East Carolina University, Greenville

30309

Shepherd Spinal Center, Atlanta

33136

Miami Center to Cure Paralysis at the Univ. of Miami School of Medicine, Miami

33351

Rehabilitation Hospital, Sunrise

35209

Lakeshore Rehabilitation Hospital, Birmingham

44106

Cleveland VAMC, Cleveland

45216

Drake Center, Cincinnati

49503

Mary Free Bed Hospital & Rehabilitation Center, Grand Rapids

55905

Mayo Clinic, Rochester

58501

Clinical Research Services, Bismarck

59802

Montana Neuroscience, Missoula

60453

Advocate Christ Medical Center-Dept. of Physical Medicine & Rehabilitation-EMG, Oak Lawn

60611

Rehabilitation Institute of Chicago, Chicago

62702

Springfield Clinic-Neuroscience Institute, Springfield

63110

Washington University School of Medicine, Div. of Rehab/Neurology, St Louis

72205

Baptist Medical Center, Little Rock

84132

Rehabilitation Services University of Utah Hospitals and Clinics, Salt Lake City

85013

Barrow Neurological Institute, Phoenix

91005

Neuro-Therapeutics, Inc, Pasadena

94304

VA Palo Alto Health Care System, Palo Alto

02114

Spaulding Rehabilitation Hospital, Boston

02185

HEALTHSOUTH Braintree Rehabilitation Hospital, Braintree

01801

HEALTHSOUTH New England Rehabilitation Hospital, Woburn

07052

Kessler Institute of Rehabilitation, West Orange

T2N 2T9

Foothills Provincial General Hospital, Calgary

T5G 0B7

Glenrose Rehabilitation Hospital, Edmonton

V5Z 2G9

G.F. Strong Rehabilitation Centre, Vancouver

E3B 4R3

Stan Cassidy Centre for Rehabilitation, Fredericton

B3M 4K4

QEII HSC-Nova Scotia Rehabilitation Centre, Halifax

N6C 5J1

Parkwood Hospital Site, St. Joseph's Health Care, London

K1H 8M2

The Rehabilitation Centre, Ottawa

M5G 3V9

Toronto Rehabilitation Institute, Lyndhurst Centre, Toronto

Sponsors
All Listed Sponsors
lead

Acorda Therapeutics

INDUSTRY

NCT00041717 - Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury | Biotech Hunter | Biotech Hunter